Education
About Us
Working with TipRanks
Follow Us
BKIE - ETF AI Analysis
Top Page
BNY Mellon International Equity ETF (BKIE)
Rating:66Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Several key positions, such as ASML Holding NV and Nestlé SA, have delivered strong year-to-date performance, supporting the ETF’s overall returns.
Low Expense Ratio
The ETF charges a very low expense ratio, making it cost-effective compared to many other international equity funds.
Broad Geographic Diversification
The fund invests across multiple countries, including Japan, the UK, and the USA, reducing reliance on any single market.
Negative Factors
Underperforming Holdings
Some top holdings, such as SAP SE and Toyota Motor, have lagged in year-to-date performance, potentially dragging down returns.
Sector Concentration in Financials
The ETF has significant exposure to the financial sector, which could increase vulnerability to sector-specific risks.
Limited Exposure to Emerging Markets
The fund focuses heavily on developed markets, offering minimal exposure to faster-growing emerging economies.
BKIE Historical Chart
AUM1.12B
RegionDeveloped Markets
Expense Ratio0.04%
Beta0.72
IssuerBNY Mellon
Inception DateApr 22, 2020
Dividend Yield2.61%
Asset ClassEquity
Index TrackedSolactive GBS Developed Markets ex United States Large & Mid Cap Index - Benchmark TR Gross
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume66,910
30 Day Avg. Volume40,130
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
102.41Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering964
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BKIE Summary
The BNY Mellon International Equity ETF (Ticker: BKIE) is an investment fund that focuses on stocks from companies outside the U.S., including both developed and emerging markets. It follows the Solactive GBS Developed Markets ex United States Large & Mid Cap Index, giving investors exposure to a wide range of industries and regions. Some well-known companies in this ETF include Nestlé and Toyota Motor. Investors might consider BKIE for global diversification and the potential growth opportunities in international markets. However, it’s important to know that the ETF’s performance can be impacted by fluctuations in foreign economies and currencies.
How much will it cost me?The BNY Mellon International Equity ETF (BKIE) has an expense ratio of 0.04%, which means you’ll pay $0.40 per year for every $1,000 invested. This is lower than average because it’s passively managed, tracking an index rather than relying on active management strategies.
What would affect this ETF?BKIE's focus on developed markets outside the U.S. could benefit from economic recovery in Europe and Asia, as well as growth in sectors like financials and technology, which are heavily weighted in the ETF. However, potential risks include geopolitical tensions, regulatory changes in key regions, or slower-than-expected growth in international markets, which could negatively impact top holdings like ASML and Nestlé. Additionally, currency fluctuations could affect returns for U.S.-based investors.
BKIE Top 10 Holdings
The BNY Mellon International Equity ETF (BKIE) leans heavily on financials and industrials, with names like HSBC and Royal Bank of Canada providing steady growth and bolstering the fund’s performance. Healthcare giants Roche and AstraZeneca are rising stars, benefiting from strong pipelines and strategic initiatives. On the flip side, SAP’s lagging momentum and Toyota’s mixed results are holding the fund back. With its developed markets focus, BKIE offers a global mix but remains concentrated in sectors like financials and healthcare, making it a solid choice for those seeking international diversification with a tilt toward stability.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 1.76% | $19.71M | €353.45B | 35.81% | 76 Outperform | |
| Roche Holding AG | 1.19% | $13.30M | CHF253.28B | 42.40% | 73 Outperform | |
| AstraZeneca | 1.15% | $12.85M | £208.42B | 27.75% | 80 Outperform | |
| HSBC Holdings | 1.09% | $12.22M | HK$1.99T | 46.00% | 80 Outperform | |
| Novartis AG | 1.08% | $12.03M | CHF200.79B | 20.24% | 80 Outperform | |
| Nestlé SA | 1.07% | $11.98M | CHF197.01B | 16.44% | 71 Outperform | |
| SAP SE | 1.06% | $11.91M | €242.99B | -12.57% | 66 Neutral | |
| Royal Bank Of Canada | 0.99% | $11.12M | $232.28B | 33.32% | 75 Outperform | |
| Toyota Motor | 0.94% | $10.54M | ¥42.49T | 24.44% | 80 Outperform | |
| Shell (UK) | 0.89% | $9.96M | £153.44B | 7.52% | 73 Outperform |
BKIE Technical Analysis
Positive
―
Price Trends
90.27
Positive
88.73
Positive
84.28
Positive
Market Momentum
0.76
Negative
64.37
Neutral
87.33
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BKIE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 90.57, equal to the 50-day MA of 90.27, and equal to the 200-day MA of 84.28, indicating a bullish trend. The MACD of 0.76 indicates Negative momentum. The RSI at 64.37 is Neutral, neither overbought nor oversold. The STOCH value of 87.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BKIE.
BKIE Peer Comparison
Comparison Results
Performance Comparison
BKIE
BNY Mellon International Equity ETF
93.00
20.28
27.89%
GSIE
Goldman Sachs ActiveBeta International Equity ETF
―
―
―
LVHI
Legg Mason International Low Volatility High Dividend ETF
―
―
―
IMTM
iShares MSCI Intl Momentum Factor ETF
―
―
―
INTF
iShares MSCI Intl Multifactor ETF
―
―
―
IDMO
Invesco S&P International Developed Momentum ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents